Dodero A, Guidetti A, Marino F, Tucci A, et al. Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome. Haematologica 2021 Jul 22. doi: 10.3324/haematol.2021.278638.
PMID: 34289655